Received: 29 October 2020
Accepted: 22 January 2021
First Online: 25 February 2021
Ethics approval and consent to participate
: Ethical approval for this study (Ethics Committee of the Affiliated Hospital of Jiaxing University) was provided by the Ethics Committee of the Affiliated Hospital of Jiaxing University (LS2020-298), Jiaxing, China on October 1, 2020. This study was conducted following the principles outlined in the Declaration of Helsinki. The study protocol was registered in the Chinese Clinical Trial Register (ChiCTR2000038264, links to registration documents: ExternalRef removed), The Chinese Clinical Trial Registration date is September 15, 2020 (15/09/2020), and the date of patient enrollment is September 17, 2020 (17/09/2020).
: All participants provided written informed consent before study enrollment.
: The authos declare that they have no competing interest.